Work

Phase III AXIS trial of axitinib versus sorafenib in metastatic renal cell carcinoma: Updated results among cytokine-treated patients.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.4546

Authors: M. Dror Michaelson, Brian I. Rini, Bernard J. Escudier, Joseph Clark, Bruce Redman, Jamal Christo Tarazi, Brad Rosbrook, Sinil Kim, Robert John Motzer

Institutions: Massachusetts General Hospital, Cleveland Clinic, Institut Gustave Roussy, Loyola University Medical Center, Loyola University Chicago, University of Michigan, U-M Rogel Cancer Center, Pfizer (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2595147207

Cites:

Cited by: 4

Related to: 10